---
title: "Newcleo soars 16% during regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302886733.md"
description: "Newcleo rose 16.13% to US$4.929. Down 34.00% over ten sessions and down 52.44% from IPO price."
datetime: "2026-10-23T13:54:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302886733.md)
  - [en](https://longbridge.com/en/news/302886733.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302886733.md)
generator: "portal-rs"
---

# Newcleo soars 16% during regular trading

Newcleo (NWCL.US) soared more than **16%** during regular trading to **$4.929**.

The stock is down 34.00% over the past ten sessions and down 52.44% from its IPO price. It sits 25.42% above its 52-week low of US$3.930. The intraday swing reached 14.84%.

The Nasdaq Composite is down 0.60% over the past five sessions and up 11.80% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [NWCL.US](https://longbridge.com/en/quote/NWCL.US.md)

## Related News & Research

- [QUOTES-People react to US AI chip curbs that threaten data centre boom](https://longbridge.com/en/news/305767058.md)
- [Jim Cramer says Nvidia’s leadership shake-up won’t derail the AI trade](https://longbridge.com/en/news/305736094.md)
- [Marvell outlines custom HBM design approach at 2026 OCP Global Summit](https://longbridge.com/en/news/305857411.md)
- [Nvidia has lost $2 trillion in value. Here's what options traders expect from earnings](https://longbridge.com/en/news/305815593.md)
- [MPs ask what the break clause was for as Palantir wins two more years in the NHS](https://longbridge.com/en/news/305803837.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**